DS HEALTHCARE GROUP, INC. (OTCMKTS:DSKX) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On May 16, 2017 the Board of Directors of DS Healthcare Group, Inc. (the “Company”) received notice that Estella Ng was resigning as a Director from the Board of Directors for personal reasons, effective immediately. Elina Yuabov was appointed chairperson of the Audit Committee previously chaired by Mrs. Ng. The company has begun a search to replace Mrs. Ng.
About DS HEALTHCARE GROUP, INC. (OTCMKTS:DSKX)
DS Healthcare Group, Inc., doing business as DS Laboratories, is a personal care, product development and marketing company. The Company develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs. Its technologies include Liposome Technology, which acts as a carrier agent, and is designed to enhance the act ion of the active ingredients in its products, and Nanosome Technology, which acts as a delivery vehicle, and is designed to infuse active compounds into targeted cells. The Company products are primarily sold under its DS Laboratories brand. It also sells certain products under its Polaris Labs and Sigma Skin brands. It markets and sells these products through salons, spas, department stores, specialty retailers and distributors. The Company offers products under three product categories: Hair Care, Skin Care and Personal Care. DS HEALTHCARE GROUP, INC. (OTCMKTS:DSKX) Recent Trading Information
DS HEALTHCARE GROUP, INC. (OTCMKTS:DSKX) closed its last trading session 00.000 at 0.100 with 500 shares trading hands.
